These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19470383)

  • 21. The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.
    Goodman WG; Hladik GA; Turner SA; Blaisdell PW; Goodkin DA; Liu W; Barri YM; Cohen RM; Coburn JW
    J Am Soc Nephrol; 2002 Apr; 13(4):1017-1024. PubMed ID: 11912261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.
    Lopez I; Aguilera-Tejero E; Mendoza FJ; Almaden Y; Perez J; Martin D; Rodriguez M
    J Am Soc Nephrol; 2006 Mar; 17(3):795-804. PubMed ID: 16467452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
    Nagano N; Nemeth EF
    J Pharmacol Sci; 2005 Mar; 97(3):355-60. PubMed ID: 15781990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats.
    Chin JI; Miller SC; Wada M; Nagano N; Nemeth EF; Fox J
    J Am Soc Nephrol; 2000 May; 11(5):903-911. PubMed ID: 10770968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
    Lomonte C; Vernaglione L; Chimienti D; Bruno A; Cocola S; Teutonico A; Cazzato F; Basile C
    Clin J Am Soc Nephrol; 2008 May; 3(3):794-9. PubMed ID: 18322048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats.
    Mendoza FJ; Lopez I; Canalejo R; Almaden Y; Martin D; Aguilera-Tejero E; Rodriguez M
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F605-13. PubMed ID: 19091789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?
    Goodman WG
    Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):355-60. PubMed ID: 15931004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.
    Nemeth EF; Heaton WH; Miller M; Fox J; Balandrin MF; Van Wagenen BC; Colloton M; Karbon W; Scherrer J; Shatzen E; Rishton G; Scully S; Qi M; Harris R; Lacey D; Martin D
    J Pharmacol Exp Ther; 2004 Feb; 308(2):627-35. PubMed ID: 14593085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
    Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
    J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
    Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
    Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
    J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
    Sakai M; Tokunaga S; Kawai M; Murai M; Kobayashi M; Kitayama T; Saeki S; Kawata T
    PLoS One; 2020; 15(4):e0232428. PubMed ID: 32343734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
    Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
    J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV; Yang J; Fernandez E; Dusso A
    Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K; Negi S; Hatamura I; Sakaguchi T; Saji F; Kunimoto K; Mizobuchi M; Imazeki I; Ooshima A; Akizawa T
    J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E; Olgaard K
    Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of AMG 416 and cinacalcet in rodent models of uremia.
    Walter S; Baruch A; Alexander ST; Janes J; Sho E; Dong J; Yin Q; Maclean D; Mendel DB; Karim F; Johnson RM
    BMC Nephrol; 2014 May; 15():81. PubMed ID: 24884838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.